SAN FRANCISCO – Patients with severe tricuspid regurgitation (TR) have sustained health improvement when undergoing tricuspid valve transcatheter edge-to-edge repair (T-TEER) with the TriClip system compared with patients who undergo medical therapy alone, a secondary analysis of the TRILUMINATE Pivotal trial shows.